Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000400977

Medchemexpress LLC Lecozotan hydrochloride | 433282-68-9 | 98.7% | 520.02 | 5 MG
SDP

Catalog No. 5000400977
Encompass_Preferred

Lecozotan hydrochloride (SRA-333) hydrochloride is an orally active and selective antagonist of 5-HT1A with a Ki of 4.5 nM for cloned human 5-HT1A receptor. It enhances the stimulated release of glutamate and acetylcholine in the hippocampus and possesses cognitive-enhancing properties. This product has the potential for mild-to-moderate Alzheimer's disease (AD) research.

  • Orally active and selective 5-HT1A antagonist.
  • Enhances the release of glutamate and acetylcholine in the hippocampus.
  • Possesses cognitive-enhancing properties.
  • Potential for mild-to-moderate Alzheimer's disease research.

Catalog No. 50-004-00977 Supplier Medchemexpress LLC Supplier No. HY19742A5MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Lecozotan hydrochloride (SRA-333) hydrochloride is an orally active and selective antagonist of 5-HT1A with a Ki of 4.5 nM for cloned human 5-HT1A receptor. It enhances the stimulated release of glutamate and acetylcholine in the hippocampus and possesses cognitive-enhancing properties. This product has the potential for mild-to-moderate Alzheimer's disease (AD) research.

  • Orally active and selective 5-HT1A antagonist.
  • Enhances the release of glutamate and acetylcholine in the hippocampus.
  • Possesses cognitive-enhancing properties.
  • Potential for mild-to-moderate Alzheimer's disease research.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.